• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA approves IND for Ananda Scientific’s PTSD treatment with liquid structure delivery tech

May 18, 2022 By Sean Whooley

Ananda Scientific LogoAnanda Scientific announced that it received an FDA investigational new drug (IND) approval for a post-traumatic stress disorder (PTSD) treatment.

The company will collaborate with the University of Nebraska Medical Center to conduct a clinical trial, led by Dr. Mathew Rizzo, Reynolds Professor and Chair of the UNMC Department of Neurological Sciences and Chief Physician for neurological services at Nebraska Medicine.

According to a news release, the study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in Ananda’s proprietary delivery technology.

“Advancing evidence-based research into new therapeutics to provide a large PTSD patient population with new innovative treatment options is a key objective for our research team,” Rizzo said in the release. “We are delighted to be collaborating with Ananda Scientific on this trial.”

The Phase II, double-blind, placebo-controlled, randomized clinical study is set to enroll 240 participants to evaluate the safety and efficacy of Nantheia ATL5, delivered through Ananda’s Liquid Structure delivery technology, which makes cannabinoids and other plant-derived compounds highly bioavailable, water-soluble and shelf-life-stable

“This is our second clinical trial targeting PTSD. We are excited that UNMC’s research team has partnered with us to evaluate our promising drug for this very debilitating condition,” Ananda CEO Sohail R. Zaidi said. “It is an important step in our efforts to provide patients with PTSD with potentially improved therapeutic options.”

Filed Under: Clinical Trials, Drug-Device Combinations, Food & Drug Administration (FDA), Neurological Tagged With: Ananda Scientific

IN CASE YOU MISSED IT

  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS